|
|
(HealthNewsDigest.com) – Julie Vose, M.D., an oncologist for the University of Nebraska Medical Center and its hospital partner, The Nebraska Medical Center, has been elected president of the American Society of Clinical Oncology (ASCO) for a one-year term beginning in June 2015.
Dr. Vose will take office as president-elect during the ASCO annual meeting in Chicago in June 2014.
Dr. Vose is the Neumann M. and Mildred E. Harris Professorial Chair and chief of the oncology/hematology division in theUNMC Department of Internal Medicine, as well as the associate director of clinical research and co-chair of the lymphoma program at the Fred & Pamela Buffett Cancer Center.
Since joining ASCO in 1991, she has served on the board of directors, as chair of the Cancer Education Committee and is the current chair-elect of the Integrated Media and Technology Committee.
“ASCO is a very diverse and multifaceted organization with so much to offer its membership,” Dr. Vose said. “I am excited to serve the ASCO membership as president and to make a difference for oncology professionals and our patients.”
Dr. Vose cited the recent enhancements in the society’s educational offerings, quality improvement, and broadened advocacy as areas where her experience and training can add to the current ASCO activities, including CancerLinQ, ASCO’s groundbreaking health information technology initiative to achieve higher quality, higher value cancer care with better outcomes for patients
Ken Cowan, M.D., Ph.D., director of the Fred & Pamela Buffett Cancer Center, called the election a great honor for Dr. Vose and UNMC.
“She is an internationally recognized leader in clinical trials in lymphoma,” he said. “As the leader of the largest organization of clinical oncologists, she will be able to have a major impact on the future directions of clinical research and clinical care in cancer.”
Dr. Vose’s election and involvement in ASCO and other national oncology organizations are a credit to UNMC as well as Dr. Vose, said James Armitage, M.D., the Joe Shapiro Professor of Internal Medicine in the UNMC Division of Oncology/Hematology.
“I’m incredibly proud of Julie and what she’s accomplished,” Dr. Armitage said. “This is the most visible and one of the most important oncology positions in the world. It reflects her excellence in clinical medicine and research.”
ASCO is the world’s leading professional organization representing physicians who care for people with cancer. With more than 30,000 members, ASCO is committed to improving cancer care through scientific meetings, educational programs and peer-reviewed journals. ASCO is supported by its affiliate organization, the Conquer Cancer Foundation, which funds ground-breaking research and programs that make a tangible difference in the lives of people with cancer. For ASCO information and resources, visit www.asco.org. Patient-oriented cancer information is available at www.cancer.net.
ASCO’s board of directors is comprised of oncology leaders who are elected to positions reflecting various specialties within the oncology field.
Through world-class research and patient care, UNMC generates breakthroughs that make life better for people throughout Nebraska and beyond. Its education programs train more health professionals than any other institution in the state. Learn more at unmc.edu and follow us on social media.
###
For advertising and promotion on HealthNewsDigest.com, call Mike McCurdy: 877-634-9180 or [email protected]. We have over 7,000 journalists as subscribers.